key: cord-0316050-fvl0ldx6
authors: Ewald, Jan; Jansen, Paul Mathias; Brunke, Sascha; Hiller, Davina; Luther, Christian H.; González-Díaz, Humbert; Dittrich, Marcus T.; Fleißner, André; Hube, Bernhard; Schuster, Stefan; Kaleta, Christoph
title: The landscape of toxic intermediates in the metabolic networks of pathogenic fungi reveals targets for antifungal drugs
date: 2021-09-06
journal: bioRxiv
DOI: 10.1101/2021.09.05.459012
sha: 396beb3d7cf21b5400eeafa2223795065b2bba99
doc_id: 316050
cord_uid: fvl0ldx6

The burden of fungal infections for humans, animals and plants is widely underestimated and comprises deadly infections as well as great economic costs. Despite that, antifungal drugs are scarce and emergence of resistance in fungal strains contributes to a high mortality. To overcome this shortage, we propose toxic intermediates and their controlling enzymes in metabolic pathways as a resource for new targets and provide a web-service, FunTox-Networks to explore the landscape of toxic intermediates in the metabolic networks of fungal pathogens. The toxicity of metabolites is predicted by a new random forest regression model and is available for over one hundred fungal species. Further, for major fungal pathogens, metabolic networks from the KEGG database were enriched with data of toxicity and regulatory effort for each enzyme to support identification of targets. We determined several toxic intermediates in fungal-specific pathways like amino acid synthesis, nitrogen and sulfur assimilation, and the glyoxylate bypass. For the latter, we show experimentally that growth of the pathogen Candida albicans is inhibited when the detoxifying enzymes Mls1 and Hbr2 are deleted and toxic glyoxylate accumulates in the cell. Thus, toxic pathway intermediates and their controlling enzymes represent an untapped resource of antifungal targets.

regulatory strategies in fungal pathways as well as to elucidate key enzymes regulating pathway flux [17] . In recent 23 years, we and others have uncovered optimality principles behind fast pathway activation strategies and efficient 24 pathway regulation across a wide range of bacteria [18] [19] [20] [21] [22] [23] [24] , which are in principle transferable to eukaryotes such as 25 fungi, too. To combat pathogens, our previous observation that enzymes upstream of toxic intermediates are tightly 26 regulated is of special interest, since we hypothesized that an upregulation (downregulation) of key enzymes regulating 27 flux before (after) a toxic intermediate can lead to self-poisoning [23] . Further, as shown across prokaryotes [23], the 28 inference of metabolic hubs and key regulated enzymes by estimators like the promoter length can be used in a reverse 29 approach to identify highly regulated enzymes and to support target identification for potential antimicrobials. This 30 reasoning provides a new avenue for the identification of drug targets using endogenously produced cytotoxins. While 31 metabolic networks have recently been investigated extensively to find key enzymes for virulence using the concept of 32 elementary modes [25] , there has been, to our knowledge, no systematic screen for toxic intermediates in metabolic 33 networks of fungal pathogens so far. However, the importance of toxic intermediates has been recognized in the fields 34 of pathway evolution [26] and metabolic engineering [27] . Similarly, an anti-cancer therapy using endogenous toxic 35 metabolites to stop cell growth was recently proposed [28] . 36 For a large-scale prediction of toxicity across multiple organisms, quantitative structure -activity relationship 37 (QSAR) models have proven to be valuable in in silico screening of inhibitors [29, 30] , in improving yield by identification 38 of toxic intermediates [31, 32] and in risk assessment [33, 34] . These machine learning approaches can help to fill the 39 gap between empirical measured toxicity data in databases like ChEMBL [35] and pathway intermediates which have 40 unknown toxicity. For fungi, Prado-Prado et al. [36] developed a multi-target spectral moment QSAR to classify drugs 41 with activity against several species. However, to take advantage of novel machine learning approaches as well as 42 much larger toxicity assays stored in the ChEMBl-database, we here used a random forest regression model to predict 43 the toxicity of intermediates in fungal metabolism based on chemical features. Using a multi-output model [37, 38] , 44 we were able to include data from all fungi with toxicity measurements as well as different types of measurement 45 of toxicity to train a single regression model for different fungal species and additional models for host organisms. 46 Moreover, we integrated our predictions with data on the degree of regulation of individual enzymes in metabolic 47 networks derived from KEGG [39] . To this end intra-species protein-protein interactions networks were inferred 48 using the newly developed FungiWeb database (https://fungiweb.bioapps.biozentrum.uni-wuerzburg.de) and 49 used here to overcome the lack of regulatory data like large-scale transcription factor networks in fungal species. 50 The enriched networks together with a cytotoxicity prediction can be displayed in a web-service FunTox-Networks 51 (http://funtox.bioinf.uni-jena.de).

As proof-of-principle for the use of our tool to identify targets for the enrichment of antifungal intermediates, we 53 used FunTox-Networks to identify several toxic intermediates in fungal-specific pathways. As promising targets, we 54 identified toxic intermediates and their controlling enzymes in pathways of nitrogen and sulfur assimilation, in amino acid 55 synthesis, and in the catabolism of fatty acids as alternative carbon sources. Especially for the latter, where glyoxylate is 56 a toxic intermediate, we show that detoxifying enzymes like malate synthase (Mls1) and an aminotransferase (Hbr2) are 57 potential targets for novel antifungal drugs. Based on the toxicity assay data in the ChEMBL database, we trained separate QSAR regression models for the 61 prediction of metabolite toxicity in fungal species and their human as well as murine host (see section 4.1 for details). 62 After carefully filtering wrong annotations and removal of outliers the data set for fungal species included 122,474 63 data points for 112 fungal species, 653,035 data points for human cells and 10,703 data points for mice (see section 4.1 64 for details). Due to the best performance among other regression models on a subset of the data, the random forest 65 regression approach was chosen to build the QSAR models (see Supp. 6). The final random forest regression model for 66 fungal species obtained a reasonable coefficient of determination of R 2 = 0.64, which is slightly lower for the models 67 of human (R 2 = 0.57) and murine (R 2 = 0.59) cells. The model quality is underlined by low root mean squared error 68 (RMSE) values between 0.30 (fungi), 0.30 (human), and 0.32 (mice). For our fungal model we fulfill the recommended 69 criteria [40] of a high R 2 > 0.6 and a low RMSE, which should be lower than 10 % of the range of predicted toxicity 70 values (between -1.73 and 4.59 in training data). Other QSAR toxicity regression models achieve higher predictive 71 power but lack universality by considering only a single species like Escherichia coli [32] or by focusing on a certain group 72 of substances with even more precise predictions [41] . 73 While our random forest regression models show good performances on test and training data, we further used 74 annotated compounds from the KEGG database to validate the predictions of our models. To this end, we predicted 75 the toxicity of compounds with biological roles like antibiotics or carbohydrates in important fungal species and host 76 organisms (see Fig. 1A ). As expected, antifungal compounds were predicted to be significantly more toxic than non-77 antibiotic compounds in fungal species (Wilcoxon rank-sum test P < 1 −16 ). The regression model clearly discriminates 78 antifungals also from other antibiotics like antibacterials (Wilcoxon P < 1 −16 ). One should note that toxicity of 79 antibiotics is relatively high even in hosts, which is reasonable since many antibiotics cause side effects harming human 80 cells and therefore are often not applied in high concentrations [42, 43] . Our model predicts carbohydrates as the least 81 toxic compound group in fungi and other organism which is in line with their common biological functions and their high 82 F I G U R E 1 A Toxicity prediction of KEGG compounds and their categories in fungi and host organisms. Distribution of toxic concentration are depicted in yellow for antibiotics and in blue for common metabolites. B Applicability Domain of the QSAR model based on a PCA of molecular descriptors (descriptor space) with the exemplary metabolites (red): ATP (1), glyoxylate (2), amphotericin B (3), fluconazole (4). The density of learning data in descriptor space is depicted from dark blue to yellow. C Distribution of metabolites from KEGG based in the same descriptor space as in A and toxicity in C. albicans indicated in gradient from yellow (toxic) to black (non-toxic). abundance in standard growth media and diet. From these results we conclude that our QSAR model is able to estimate 83 the toxicity of metabolites across a wide range of compound classes and organisms. 84 A main goal behind our QSAR model is that it is accessible for all researchers and we therefore provide the web-85 service FunTox-Networks. In addition to the toxicity prediction of KEGG metabolites, the web-service can be queried to visualize the descriptor space of training data (see Fig. 1B ). Using this presentation we see that training data covers not 93 only the known toxic antifungals like fluconazole or amphotericin B well, but is also nearly identical to the descriptor 94 space obtained from all metabolites of pathways in KEGG (see Fig. 1C ). 95 Importantly, although the toxicity prediction is mainly based on molecular descriptors, we did not observe distinct 96 regions or clusters in the principal component analysis of molecular descriptors for toxic and non-toxic metabolites. This 97 observation indicates that toxic metabolites are uniformly distributed across the entire chemical space (see Fig. 1C ). 98 Moreover, this demonstrates that our random forest regression model is able to recognize small structural differences 99 that are associated with toxicity. An example is the well known toxic byproduct methylglyoxal (C 3 H 4 O 2 ) formed during 100 glycolysis [48] . Our model correctly predicts a high toxicity of methylglyoxal e.g. in the common fungal pathogen Candida 101 albicans (Z t ox = −0.177) and no toxicity of the structurally highly similar metabolite pyruvate (C 3 H 4 O 3 , Z t ox = 0.007). KEGG pathways which contain many toxic intermediates are fatty acid metabolism (map01040, map00062, map00071), 122 propanoate metabolism (map00640), glyoxylate metabolism (map00630), and porphyrin metabolism (map00860). 123 Because we can predict toxicity in fungal species as well as for their potential hosts, our web-service additionally 124 provides an interactive plot to compare the toxicity of KEGG metabolites in two species. This enables the identification 125 of metabolites which are more toxic to the pathogen than to host cells or vice versa (see Fig. 2 To prove its usefulness, we employed FunTox-Networks to search for enzymes which are suitable targets for antifungal 147 interventions. We limited our search to metabolic pathways which are specific to fungi and enzymes which have no 148 homolog in humans. Since fungal species are able to grow in a great variety of conditions, many fungal specific metabolic 149 pathways with toxic intermediates are related to resource acquisition, such as carbon, nitrogen, and sulfur assimilation 150 (see Fig. 3 ). We found known and new targets in the synthesis of amino acids and in fatty acid metabolism, as well as in 151 ergosterol synthesis, which is a main target for the antifungal class of azoles. 152 Ergosterol synthesis is especially suitable for antifungal intervention in our sense, as azoles are not only inhibiting 153 the synthesis by blocking the Lanosterol-14α-demethylase, but also lead to the accumulation of toxic 14-methyl sterol 154 intermediates like 14α-methyl-3, 6 F I G U R E 3 Schematic overview of target pathways with selected toxic intermediates (yellow) in a fungal cell (dark green). the lung, gut or skin [55, 56] , the importance of metabolic pathways for virulence varies across fungal species. For the 158 target pathways shown in Fig. 3 we found that the aspartate as well as the methionine-branch of amino acid synthesis is 159 linked to virulence [57] and especially homocysteine is known to accumulate to toxic levels if the methionine synthase 160 gene (MET6) is deleted in C. albicans [58] . In contrast, the importance of lysine and histidine biosynthesis for fungal 161 virulence is unclear due to contradictory results in common fungal pathogens [57] . Interestingly, the acquisition of 162 inorganic nitrogen and sulfur sources is not required for full virulence and assimilation of these elements is possible 163 via multiple organic and inorganic substrates in pathogenic fungi like A. fumigatus or C. albicans [59-61]. However, a 164 recent study shows that sulfite detoxification is actively controlled and enhances growth in C. albicans suggesting that 165 the involved enzymes and regulators are suitable targets for antifungal interventions [62] . 166 In these metabolic pathways we considered the toxic intermediate glyoxylate with its consuming enzyme malate 167 synthase to be the most promising target. Firstly, glyoxylate is known to be highly reactive, and eukaryotic cells isolate 

To verify the potential of toxic intermediates as antifungal drug targets, we experimentally investigated the glyoxylate 181 bypass in C. albicans. In addition to the two key enzymes Icl1 and Mls1, the genome annotation as well as metabolic 182 databases like KEGG suggest two additional enzymes which can detoxify glyoxylate (see Fig. 4A ). We therefore analyzed 183 the transcriptional response of C. albicans to various organic acids [67] . In addition to ICL1 or MLS1, we created a deletion 184 strain lacking the putative alanine glyoxylate aminotransferase gene (HBR2), because it shows a strong coregulation 185 with the glyoxylate bypass enzymes (see Fig. 4B ) and its homolog in baker's yeast codes for an enzyme that is able to 186 detoxify glyoxylate to pyruvate [68] . In contrast to this, the glyoxylate reductase gene (GOR1) is coregulated with the 187 isocitrate dehydrogenase gene IDP2 of the TCA cycle (see Fig. 4A inhibition (see Fig. 4C ). This supports the view that glyoxylate detoxification is ensured by both, Mls1 and Hbr2. 194 C. albicans faces a glucose-poor environment during phagocytosis and relies on the glyoxylate bypass for survival. 195 Having shown that C. albicans depends on Mls1 and Hbr2 for glyoxylate detoxification, we performed additional ex-196 periments where glyoxylate is produced intracellularly. To this end, we tested growth with ethanol as the only carbon 197 source. As expected, the wild-type and hbr 2∆/∆ strains grew slowly on ethanol, and the glyoxylate bypass mutants 198 were unable to grow. In addition to growth inhibition, we observed that strains lacking the glyoxylate detoxification 199 enzymes (mls1∆/∆ and mls1∆/∆ hbr2∆/∆) die off earlier when ethanol is the sole carbon source than the non-glyoxylate 200 producing strain i cl 1∆/∆, which otherwise is similarly unable to grow (see Fig. 4D ). While we focused here on fungal pathogens of humans, fungi that infect plants and animals are a significant concern 229 in agriculture and biodiversity, leading not only to high economic costs but also affecting human health, since they For organisms where neither transcription factors nor a PPI score are available (see Tab. 2), the promoter length 319 determined as the intergenic distance was used as in previous studies for prokaryotes [21, 23] . Promoter lengths have 320 proven to be good proxies of regulatory effort due to the reduced genome sizes of fungi compared to higher eukaryotes 321 which makes a loss of non-functional sequences more likely [91] . In consequence, the length of promoter regions should 322 reflect the number of functional elements such as transcription factor binding sites contained in them. In agreement 323 with this hypothesis, we found for the well-studied regulatory network of yeast that promoter length correlates with 324 the number of transcription factors (see Supp. 8). 325 We enriched pathways maps with color-coded information on regulatory effort and toxicity information were considered as significant with values *p < 0.05, **p < 0.01, ***p < 0.001. 

Emerging fungal infections in immunocompromised patients

The changing epidemiology of invasive fungal infections. Human Fungal 413 Pathogen Identification

Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring 415 Harbor perspectives in medicine

The evolution of drug resistance in clinical isolates of 417 Candida albicans

Antifungal drugs: what brings the future? 419

Current antimycotics, new prospects, and future approaches to antifungal therapy

Metabolism in fungal pathogenesis

Amino acid metabolism and transport mechanisms as potential antifungal targets. Interna-427 tional

Potential antifungal targets based on glucose metabolism pathways of Candida 429 albicans

Survival Strategies of Pathogenic Candida Species 431 in Human Blood Show Independent and Specific Adaptations

Trends in mathematical modeling of host-pathogen interac-433 tions

Flux, toxicity, and expression costs generate 452 complex genetic interactions in a metabolic pathway

Dynamic metabolic control: towards precision engineering of 454 metabolism

Endogenous toxic metabolites and implications in cancer therapy

A QSAR model for in silico screen-458 ing of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins

3D-QSAR in drug design-a review

A retrosynthetic biology approach to metabolic pathway design for 463 therapeutic production

Compound toxicity screening and structure-activity relation-465 ship modeling in Escherichia coli

In silico toxicology: computational methods for the prediction of chemical toxicity

Understanding the basics of QSAR for applications in pharmaceutical sciences and risk assess-469 ment

The ChEMBL bioactivity database: an update

Multi-target spectral moment: QSAR for antifungal 473 drugs vs. different fungi species

Multi-475 output Model with Box-Jenkins Operators of Quadratic Indices for Prediction of Malaria and Cancer Inhibitors Tar-476

Brain-inspired cheminformatics of 478 drug-target brain interactome, synthesis, and assay of TVP1022 derivatives

KEGG: new perspectives on genomes, pathways, diseases 480 and drugs

Beware of R 2: simple, unambiguous assessment of the prediction accuracy of 482 QSAR and QSPR models

Assessment of bromide-based ionic liquid toxicity toward aquatic organisms 484 and QSAR analysis

Antibiotic toxicity, interactions and resistance development

The refusal of the Society to accept antibiotic toxicity: missing opportunities for therapy of severe 487 infections

SMILES. 2. Algorithm for generation of unique SMILES notation

InChI-the worldwide chemical structure identifier standard

OECD. Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Mod-493 els

Three useful dimensions for domain applicability in QSAR models using random forest

Methylglyoxal, the dark side of glycolysis

Free heme toxicity and its detoxification systems in human

Overview of coenzyme A metabolism and its role in cellular toxicity

Formic acid and acetic acid induce a pro-503 grammed cell death in pathogenic Candida species

Glucose homeostasis is important for immune 505 cell viability during Candida challenge and host survival of systemic fungal infection

Comparative transcriptomics of Aspergillus fumi-508 gatus strains upon exposure to human airway epithelial cells

Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces 510 cerevisiae

Opportunistic and pathogenic fungi

Tissue-resident macrophages in fungal infections

Inhibitors of amino acids biosynthesis as antifungal agents

The gene for cobalamin-independent methionine synthase is essential in Candida 516 albicans: a potential antifungal target

Deciphering metabolic traits of the fungal pathogen Aspergillus fumigatus: redundancy vs. essen-518 tiality

Overview of carbon and nitrogen catabolite metabolism in the virulence 520 of human pathogenic fungi

Exploration of sulfur assimilation of Aspergillus 522 fumigatus reveals biosynthesis of sulfur-containing amino acids as a virulence determinant

Adaptation of Candida albicans to Reactive Sulfur Species

Reactive oxygen species, antioxidant systems and 527 nitric oxide in peroxisomes

The glyoxylate cycle is required for fungal virulence

Description of the interaction between Candida 530 albicans

Glyoxylate detoxification is an essential function of 532

malate synthase required for carbon assimilation in Mycobacterium tuberculosis

The transcriptional stress response of Candida albicans 535 to weak organic acids

Alanine: glyoxylate aminotransferase of Saccharomyces cerevisiae-537 encoding gene AGX1 and metabolic significance

A feast for Candida: metabolic plasticity confers an edge for virulence

Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as anti-541 fungal agents

Emerging fungal threats to animal, plant 543 and ecosystem health

Engineering dynamic pathway 545 regulation using stress-response promoters

Manufacturing molecules through metabolic engineering

Glycolic acid production in the engineered 548 yeasts Saccharomyces cerevisiae and Kluyveromyces lactis

Biotechnological production of glycolic acid and ethylene glycol: 550 current state and perspectives

Mordred: a molecular descriptor calculator

RRegrs: an R package for 554 computer-aided model selection with multiple regression models

Random forests

A fast implementation of random forests for high dimensional data in C++ and R

How Many Trees in a Random Forest? In: International Workshop on Machine 559 Learning and Data Mining in Pattern Recognition Springer

Comments on the definition of the Q2 parameter for QSAR validation

Comparison of different approaches to define 563 the applicability domain of QSAR models

KEGGREST: Client-side REST access to KEGG

RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory 566 networks in human and mouse

Integrated inference and evaluation of host-568 fungi interaction networks

Protein interaction data curation: the International 570 Molecular Exchange (IMEx) consortium

InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic

The Candida Genome Database 574 (CGD), a community resource for Candida albicans gene and protein information

The Aspergillus Genome Database: mul-577 tispecies curation and incorporation of RNA-Seq data to improve structural gene annotations

MINT, the molecular interaction database: 2012 580 update

Fungal genes in context: genome architecture reflects regulatory complexity and func-582 tion

Cytoscape: a software environment for integrated 584 models of biomolecular interaction networks

KEGGscape: a Cytoscape app for pathway data integration

shiny: Web Application Framework for R

The MetaCyc database of metabolic 590 pathways and enzymes

New modules for PCR-based gene targeting in Candida albicans: 592 rapid and efficient gene targeting using 100 bp of flanking homology region

Rapid hypothesis testing with Candida albicans through gene disruption with short 594 homology regions

The transcription factor Ndt80 does not con-596 tribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans

The YEASTRACT database: an 598 upgraded information system for the analysis of gene and genomic transcription regulation in Saccharomyces cerevisiae

YeastMine-an integrated data warehouse for Sac-601 charomyces cerevisiae data as a multipurpose tool-kit

10-year anniversary of a resource for 603 post-translational modification of proteins